View in EDS

Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.

Saved in:
Bibliographic Details
Title: Colistin Therapy for Urinary Tract Infections Due to Multidrug-Resistant Bacteria: Experience at a Tertiary Academic Medical Center.
Authors: Aldairem A; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alowais SA; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alshaya AI; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; Collaboration and Partnerships Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia., Alrashed M; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alqahtani T; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; College of Pharmacy, Department of Pharmaceutical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Preclinical Studies, Benefit and Risk Assessment Executive Directorate, Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia., Alharbi L; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alshehri R; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Al Dughaish ST; Clinical Pharmacy Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia., Alenazi A; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Bin Saleh K; Department of Pharmacy Practice, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.; Department of Pharmaceutical Care, King Abdulaziz Medical City (KAMC), Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Source: Infection and drug resistance [Infect Drug Resist] 2026 May 25; Vol. 19, pp. 608721. Date of Electronic Publication: 2026 May 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6973 (Print) Linking ISSN: 11786973 NLM ISO Abbreviation: Infect Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1178-6973
DOI:10.2147/IDR.S608721